|
|
 |
|
Proceedings
Day 1 - Tuesday, October 8, 2002

Overview
Program Chair:Kenneth L. Morand, Procter & Gamble Pharmaceuticals, Mason, Ohio

TuOA
Plenary
Joseph A. DiMasi, Director of Economic Analysis
Tufts Center for the Study of Drug Development
TuOB
Genomics/Post Genomics Trends
Discussion Leader: Steven A. Hofstadler, IBIS Therapeutics
Applying Antisense Technology for Functional Genomics and Drug Discovery
Brett Monia, ISIS Pharmaceuticals
High Throughput Genotyping Using Illumina's Bead Array Technology
David Barker, Illumina, Inc.
Modeling of Alternative Splicing in Mammalian Genomes Using Compugen's LEADs Technology
Alon Amit, Compugen
Roundtable Discussion 1
TuOC
Vendor/Exhibitor Session:
Sample Preparation & Chromatography
Ken Workowski, Tomtec
Asha A. Oroskar, Orochem Technologies, Inc.
Joseph M.Di Bussolo, Cohesive Technologies, Inc.
Development of a Novel HPLC Column Technology for Peptide Mapping and Proteomics
Tivadar Farkas, Phenomenex, Inc.
Automated Parallel Separations for LC/MS
Michael Sabatino, LEAP Technologies
A Microfluidic Device for High Throughput Separations
Hugh McManus, Nanostream, Inc.
The MS4, A New Highly Flexible HPLC Separations Module for Multidimensional Separations
Kerry Nugent, Michrom BioResources, Inc.
2-D Capillary/Nano LC as a Front-End Separations Tool for MS Proteomics
Herb Schwartz, Dionex Corporation
New Developments in LC and LC/MS for Enhancing Drug Discovery and Development Programs
Gordon S. Hunter, Gilson, Inc.
Roundtable Discussion 2
Discussion Leader: Ioannis A. Papayannopoulos, Applied BioSystems
Al Yergey, National Institutes of Health
Richard S. Johnson, Amgen, Inc.
TuOD3: Roland S. Annan, GlaxoSmithKline
Roundtable Discussion 3
TuOE
Metabonomics
Discussion Leaders: John P. Shockcor, Metabometrix Ltd.
Unusual Clinical Applications of Metabonomics
John P. Shockcor, Metabometrix Ltd.
Potential of LC/MS(MS) for Metabonomic Studies
Robert S. Plumb, Waters Corporation
Rapid Metabolite Identification by NMR - Applications and Innovations
David Wishart, CHENOMIX, Inc.
|
|